ifosfamide has been researched along with Cardiovascular Diseases in 2 studies
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pal, SK | 1 |
Yamzon, J | 1 |
Sun, V | 1 |
Carmichael, C | 1 |
Saikia, J | 1 |
Ferrell, B | 1 |
Frankel, P | 1 |
Hsu, J | 1 |
Twardowski, P | 1 |
Stein, CA | 1 |
Margolin, K | 1 |
Fetscher, S | 1 |
Brugger, W | 1 |
Engelhardt, R | 1 |
Kanz, L | 1 |
Hasse, J | 1 |
Frommhold, H | 1 |
Wenger, M | 1 |
Lange, W | 1 |
Mertelsmann, R | 1 |
1 trial available for ifosfamide and Cardiovascular Diseases
Article | Year |
---|---|
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carc | 1997 |
1 other study available for ifosfamide and Cardiovascular Diseases
Article | Year |
---|---|
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivors.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols | 2013 |